Thank you very much, Madam Chair.
I would like to thank our witnesses for being here today.
As my colleague said, you've taken the lid off some very interesting subjects. I have some questions for a couple of you, so I'm hoping to get to all of the questions I have.
I do want to talk to Dr. Hormes, because I'm from Saskatoon and I'm very proud of Canadian Light Source, CLS, which is located at the University of Saskatchewan in our city. I know that it is a world-class state-of-the-art facility that is advancing Canadian science, enhancing the competitiveness of Canadian industry, and definitely contributing to the quality of life of people around the world.
Here's what I wanted to pick up on. What we heard from you today is that synchrotrons can be used to analyze a host of processes and information obtained by researchers, and can be used to design new drugs and develop new materials for products, such as safer medical implants. You gave us some examples, but I want to give you an opportunity to share more about the new drugs and medical implants that were designed as a result of CLS.